Hippo signalling maintains ER expression and ER+ breast cancer growth

被引：0
|
作者：
Shenghong Ma
Zhengming Wu
Feng Yang
Jianmin Zhang
Randy L. Johnson
Michael G. Rosenfeld
Kun-Liang Guan
机构：
[1] University of California San Diego,Department of Pharmacology
[2] University of California San Diego,Moores Cancer Center
[3] University of California San Diego,Howard Hughes Medical Institute, Department of Medicine
[4] Roswell Park Cancer Institute,Department of Cancer Genetics and Genomics
[5] University of Texas,Department of Cancer Biology
[6] MD Anderson Cancer Center,undefined
来源：
Nature | 2021年 / 591卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：E1 / E10
相关论文
共 50 条
  • [1] Hippo signalling maintains ER expression and ER+ breast cancer growth
    Ma, Shenghong
    Wu, Zhengming
    Yang, Feng
    Zhang, Jianmin
    Johnson, Randy L.
    Rosenfeld, Michael G.
    Guan, Kun-Liang
    [J]. NATURE, 2021, 591 (7848) : E1 - E10
  • [2] Reply to: Hippo signalling maintains ER expression and ER+ breast cancer growth
    Britschgi, Adrian
    Couto, Joana Pinto
    Bentires-Alj, Mohamed
    [J]. NATURE, 2021, 591 (7848) : E11 - E12
  • [3] Reply to: Hippo signalling maintains ER expression and ER+ breast cancer growth
    Adrian Britschgi
    Joana Pinto Couto
    Mohamed Bentires-Alj
    [J]. Nature, 2021, 591 : E11 - E12
  • [4] YAP inhibits ERα and ER+ breast cancer growth by disrupting a TEAD-ERα signaling axis
    Xu Li
    Shu Zhuo
    Ting Zhuang
    Yong Suk Cho
    Guojin Wu
    Yuchen Liu
    Kun Mu
    Kai Zhang
    Peng Su
    Yingzi Yang
    Cheng Cheng Zhang
    Jian Zhu
    Jin Jiang
    [J]. Nature Communications, 13
  • [5] YAP inhibits ERα and ER+ breast cancer growth by disrupting a TEAD-ERα signaling axis
    Li, Xu
    Zhuo, Shu
    Zhuang, Ting
    Cho, Yong Suk
    Wu, Guojin
    Liu, Yuchen
    Mu, Kun
    Zhang, Kai
    Su, Peng
    Yang, Yingzi
    Zhang, Cheng Cheng
    Zhu, Jian
    Jiang, Jin
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)
  • [6] Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER+ Breast Cancer
    Formisano, Luigi
    Stauffer, Kimberly M.
    Young, Christian D.
    Bhola, Neil E.
    Guerrero-Zotano, Angel L.
    Jansen, Valerie M.
    Estrada, Monica M.
    Hutchinson, Katherine E.
    Giltnane, Jennifer M.
    Schwarz, Luis J.
    Lu, Yao
    Balko, Justin M.
    Deas, Olivier
    Cairo, Stefano
    Judde, Jean-Gabriel
    Mayer, Ingrid A.
    Sanders, Melinda
    Dugger, Teresa C.
    Bianco, Roberto
    Stricker, Thomas
    Arteaga, Carlos L.
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (20) : 6138 - 6150
  • [7] GR and ER Coactivation Alters the Expression of Differentiation Genes and Associates with Improved ER+ Breast Cancer Outcome
    West, Diana C.
    Pan, Deng
    Tonsing-Carter, Eva Y.
    Hernandez, Kyle M.
    Pierce, Charles F.
    Styke, Sarah C.
    Bowie, Kathleen R.
    Garcia, Tzintzuni I.
    Kocherginsky, Masha
    Conzen, Suzanne D.
    [J]. MOLECULAR CANCER RESEARCH, 2016, 14 (08) : 707 - 719
  • [8] Estetrol for treatment of advanced ER+ breast cancer
    Schmidt, M.
    Honig, A.
    Verhoeven, C.
    Almstedt, K.
    Battista, M.
    Lenhard, H. G.
    Krijgh, J.
    Bennink, H. Coelingh
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [9] Estetrol for treatment of advanced ER+ breast cancer
    Verhoeven, Carole
    Schmidt, Marcus
    Hoenig, Arnd
    Duennebacke, Jan
    Dutman, Ellen
    Krijgh, Jan
    Bennink, Herjan Coelingh
    [J]. CANCER RESEARCH, 2018, 78 (04)
  • [10] Modeling ER+ breast cancer dormancy in mice
    Alexandra Le Bras
    [J]. Lab Animal, 2022, 51 : 285 - 285
12345